← Back to Search

Group for Tendonitis

N/A
Waitlist Available
Led By Siddhartha Rao, MD
Research Sponsored by Vascular Solutions of North Carolina
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* \> 18 years of age undergone artery embolization interventions for the treatment of chronic pain due to osteoarthritis or other diagnoses that cause localized pain.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Summary

Embo Registry is a retrospective and prospective observational study to evaluate real world effectiveness and the use of Artery Embolization as a treatment for chronic pain with patients that have osteoarthritis and localized pain to provide symptomatic relief. This study is to determine the efficacy and validity of procedure and that following procedure patients had decreased pain and improved quality of life.

Eligible Conditions
  • Tendonitis
  • Osteoarthritis
  • Shoulder tendonitis
  • Achilles Tendonitis
  • Tenosynovitis
  • Chronic Pain
  • Shoulder Osteoarthritis

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Secondary study objectives

Trial Design

1Treatment groups
Experimental Treatment
Group I: GroupExperimental Treatment1 Intervention
For the study to determine efficacy and overall improvement of patients post artery embolization by comparing patient's pain preoperative and post operatively, if there is a decreased use of medication preoperatively compared to post procedure and increased quality of life preoperative and post procedure. Clinical outcomes of improvement will be determined by improvement of Visual Analog Scale (VAS) scores, Western Ontario and McMaster Universities Index (WOMAC), EQ-5D-5L Quality of Life Questionnaire, and to determine if patients had decrease used of medication prescribed preoperatively.

Find a Location

Who is running the clinical trial?

Vascular Solutions of North CarolinaLead Sponsor
Siddhartha Rao, MDPrincipal InvestigatorVascular Solutions of North Carolina
Amer IqbalStudy DirectorVascular Solutions of North Carolina
~667 spots leftby Jul 2027